Abstract
Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitors used in the treatment of patients with type 2 diabetes. An aryl glycoside with s......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
